JNJ vs. NVDA: Johnson & Johnson vs. NVIDIA Stock Comparison

Company Profile

Johnson & Johnson (JNJ) is classified in the Health Care sector (Pharmaceuticals, Biotechnology & Life Sciences), whereas NVIDIA (NVDA) belongs to Information Technology (Semiconductors & Semiconductor Equipment) — their GICS classifications point to very different parts of the market.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

NVIDIA (NVDA) has a highly aggressive beta of 2.28, indicating much higher sensitivity to broad-market moves, while Johnson & Johnson (JNJ) is defensive at 0.21 and tends to be less market-sensitive — a wide gap in beta profiles.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both companies show strong equity returns, but NVIDIA (NVDA) at 117.21% is the standout with ROE above its industry range; Johnson & Johnson (JNJ) at 20.02% also sits in the top quartile.

For every dollar of sales, both Johnson & Johnson (JNJ) at 16.20% and NVIDIA (NVDA) at 63.66% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

NVIDIA (NVDA) at 66.24% shows unusually strong operating efficiency — above its industry’s operating margin range — and Johnson & Johnson (JNJ) at 25.74% also operates in the top quartile.

Profitability Metrics

Growth

NVIDIA (NVDA) at 65.47% clears its industry range for revenue growth, far stronger top-line momentum than Johnson & Johnson (JNJ) at 6.05%, which is closer to a typical peer reading.

Both Johnson & Johnson (JNJ) at 90.50% and NVIDIA (NVDA) at 66.67% sit in the top peer quartile for EPS growth, so each is compounding per-share earnings faster than typical industry peers.

Growth Metrics

Financial Strength

NVIDIA (NVDA) at 4.59 keeps current ratio within its industry’s typical mid-range, while Johnson & Johnson (JNJ) at 1.02 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for JNJ.

Both Johnson & Johnson (JNJ) at 0.55 and NVIDIA (NVDA) at 0.17 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

NVIDIA (NVDA) at 0.15% pays an industry-typical yield; Johnson & Johnson (JNJ) at 1.94% is above its entire peer range — the higher number, but one that calls for a look at payout sustainability before treating it as an advantage.

NVIDIA (NVDA) at 3.54% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 80.12% pays out more than any of its peers — the most stretched cover in its group.

Dividend Metrics

Valuation

NVIDIA (NVDA) at 23.60 sits in the cheaper P/E ratio quartile, while Johnson & Johnson (JNJ) at 41.92 is closer to its industry’s usual earnings multiple — a discount for NVDA, though growth and earnings durability still matter.

Johnson & Johnson (JNJ) at 6.69 is priced about in line with its industry on P/S ratio, while NVIDIA (NVDA) at 14.88 sits in the pricier quartile — NVDA costs more per dollar of sales.

Both look rich against book: Johnson & Johnson (JNJ) at 8.16 sits in the upper P/B ratio quartile, and NVIDIA (NVDA) at 19.68 prices even higher, above its industry range.

Valuation Metrics